Frontiers in Genetics (Oct 2022)

G3BP1 regulates breast cancer cell proliferation and metastasis by modulating PKCζ

  • Shuang Liu,
  • Shaoping Tian,
  • Tianyu Lin,
  • Xin He,
  • Xin He,
  • Justin Eze Ideozu,
  • Rui Wang,
  • Yong Wang,
  • Dan Yue,
  • Hua Geng,
  • Hua Geng,
  • Hua Geng

DOI
https://doi.org/10.3389/fgene.2022.1034889
Journal volume & issue
Vol. 13

Abstract

Read online

Breast cancer is a leading cause of death and morbidity among female cancers. Several factors, including hormone levels, lifestyle, and dysregulated RNA-binding proteins, have been associated with the development of breast cancer. Ras-GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) and protein kinase C, Zeta isoform (PKCζ) are oncogenes implicated in numerous cancers, including breast cancer. However, their interaction and role in promoting breast cancer proliferation and metastasis have not been well-characterized. In the present study, we demonstrated that G3BP1 expression was elevated in breast cancer and that knockdown of G3BP1 diminished the proliferation and metastasis of breast cancer cells. Mechanistically, we identified proliferation and a series of metastasis-related properties, including chemotaxis, migration, Golgi polarity localization, and actin polymerization, that were modulated by G3BP1 knockdown. We found that G3BP1 and PKCζ were co-localized and interacted intracellularly, and they co-underwent membrane translocation under EGF stimulation. Following the knockdown of G3BP1, we observed the membrane translocation and phosphorylation of PKCζ were significantly impaired, suggesting that G3BP1 regulates the activation of PKCζ. Our findings indicate that G3BP1 plays multiple roles in breast cancer cell proliferation and metastasis. The activation of PKCζ by G3BP1 may be the specific mechanism underlying the process.

Keywords